[go: up one dir, main page]

ZA807327B - New 5,10-dihydroimidfazo(2,1-b)quinazolines,their production and pharmaceutical compositions containing them - Google Patents

New 5,10-dihydroimidfazo(2,1-b)quinazolines,their production and pharmaceutical compositions containing them

Info

Publication number
ZA807327B
ZA807327B ZA00807327A ZA807327A ZA807327B ZA 807327 B ZA807327 B ZA 807327B ZA 00807327 A ZA00807327 A ZA 00807327A ZA 807327 A ZA807327 A ZA 807327A ZA 807327 B ZA807327 B ZA 807327B
Authority
ZA
South Africa
Prior art keywords
dihydroimidfazo
quinazolines
new
production
pharmaceutical compositions
Prior art date
Application number
ZA00807327A
Other languages
English (en)
Inventor
H Ott
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA807327B publication Critical patent/ZA807327B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/19—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA00807327A 1979-11-24 1980-11-24 New 5,10-dihydroimidfazo(2,1-b)quinazolines,their production and pharmaceutical compositions containing them ZA807327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1045379 1979-11-24

Publications (1)

Publication Number Publication Date
ZA807327B true ZA807327B (en) 1982-07-28

Family

ID=4363385

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807327A ZA807327B (en) 1979-11-24 1980-11-24 New 5,10-dihydroimidfazo(2,1-b)quinazolines,their production and pharmaceutical compositions containing them

Country Status (12)

Country Link
US (1) US4372956A (xx)
EP (1) EP0029559A3 (xx)
JP (1) JPS5699486A (xx)
AU (1) AU6460480A (xx)
DK (1) DK499180A (xx)
ES (1) ES497048A0 (xx)
FI (1) FI803589L (xx)
IL (1) IL61536A0 (xx)
PT (1) PT72086B (xx)
SU (1) SU980624A3 (xx)
YU (1) YU298180A (xx)
ZA (1) ZA807327B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5117061A (en) * 1985-04-03 1992-05-26 Ethyl Corporation Process of preparing substituted anilines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
USD1041943S1 (en) * 2022-05-12 2024-09-17 HC Systems, Inc. Toilet paper housing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745216A (en) * 1969-12-18 1973-07-10 Smith Kline French Lab Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant
SU445665A1 (ru) 1972-06-30 1974-10-05 Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе Способ получени производных имидазо=/1,2=в/=хиназолона-5
US3974165A (en) * 1974-02-21 1976-08-10 Bristol-Myers Company Hypotensive agents
JPS5752352B2 (xx) * 1974-02-28 1982-11-06
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
JPS5448797A (en) * 1977-09-06 1979-04-17 Sumitomo Chem Co Ltd Tricyclic condensed pyrimidine derivative and its preparation
JPS5576878A (en) * 1978-11-14 1980-06-10 Sumitomo Chem Co Ltd Tricyclic condensed pyrimidine derivative and its acid addition salt

Also Published As

Publication number Publication date
FI803589L (fi) 1981-05-25
SU980624A3 (ru) 1982-12-07
AU6460480A (en) 1981-05-28
PT72086B (en) 1982-01-28
EP0029559A3 (en) 1981-09-30
YU298180A (en) 1983-02-28
PT72086A (en) 1980-12-01
US4372956A (en) 1983-02-08
JPS5699486A (en) 1981-08-10
IL61536A0 (en) 1980-12-31
ES8202826A1 (es) 1982-02-16
ES497048A0 (es) 1982-02-16
EP0029559A2 (en) 1981-06-03
DK499180A (da) 1981-05-25

Similar Documents

Publication Publication Date Title
IL55423A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
IL60474A (en) Cyclopeptides of the somatostatin type,their manufacture and pharmaceutical compositions containing them
IL61774A0 (en) Cyclooctapeptides,their manufacture and pharmaceutical compositions containing them
IL65167A (en) N-acyl-polypeptides,their production and pharmaceutical compositions containing them
IL57115A (en) Hydrazone-beta-lactam antibiotics,their production and pharmaceutical compositions containing them
IL74043A (en) 8alhpa-acylaminoergolines,their production and pharmaceutical compositions containing them
IL60037A0 (en) Pyrazinobenzodiazepines,their production and pharmaceutical compositions containing them
IL68576A0 (en) Azepinoindoles,their production and pharmaceutical compositions containing them
IL58415A (en) Substituted octahydro-7-phenylquinolizines,their manufacture and pharmaceutical compositions containing them
IL61603A0 (en) 2,3-indoledione derivatives their manufacture and pharmalceutical compositions containing them
IL52615A0 (en) Novel 1,5-disubstituted-2-pyrrolidones,their production and pharmaceutical compositions containing them
IL68619A0 (en) Quinazoline derivatives,their manufacture and pharmaceutical compositions containing them
IL60733A (en) 1-substituted-pyrrolidinones,their manufacture and pharmaceutical compositions containing them
IL61335A0 (en) 1-oxadethiacephalosporin derivatives, their production and pharmaceutical compositions containing them
IL59566A0 (en) Polysubstituted diazatricycles,their manufacture and pharmaceutical compositions containing them
IL61773A (en) Piperazinyl pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
IL61040A0 (en) Pyridazopyridazine derivatives,their manufacture and pharmaceutical compositions containing them
ZA807327B (en) New 5,10-dihydroimidfazo(2,1-b)quinazolines,their production and pharmaceutical compositions containing them
IL67813A0 (en) Benzothienylallylamines,their production and pharmaceutical compositions containing them
IL66146A (en) Substituted benzylidenepyrrolo-(2,1-b)quinazolinones and pyrido-(2,1-b)quinazolinones,their preparation and pharmaceutical compositions containing them
GB2169291B (en) 8a-acylaminoergolines, their production and pharmaceutical compositions containing them
IL67715A (en) 3,3-dialkyl-and 3,3-alkyleneindolene derivatives,their production and pharmaceutical compositions containing them
IL75468A (en) Naphthoxazines,their production and pharmaceutical compositions containing them
IL55869A0 (en) New 2,4-diamino-5-benzylpyrimidines, their manufacture and pharmaceutical compositions containing them
IL56696A (en) N1-glucofuranosid-6-yl-n3-nitroso-ureas,their production and pharmaceutical compositions containing them